• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状糖原合成酶激酶3β(CircGSK3β)通过微小RNA-338-3p/蛋白精氨酸甲基转移酶5/组蛋白H3赖氨酸4三甲基化(miR-338-3p/PRMT5/H3K4me3)介导程序性死亡受体配体1(PD-L1)转录,以促进乳腺癌细胞的免疫逃逸和肿瘤进展。

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

作者信息

Liang Lin, Gao Mengxiang, Li Wentao, Tang Jingqiong, He Qian, Zeng Feng, Cao Jiaying, Liu Siyi, Chen Yan, Li Xin, Zhou Yanhong

机构信息

Breast Cancer Center, Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

National Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.

出版信息

Cell Death Discov. 2024 Oct 4;10(1):426. doi: 10.1038/s41420-024-02197-8.

DOI:10.1038/s41420-024-02197-8
PMID:39366935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11452702/
Abstract

Circular RNA (circRNA) plays a pivotal role in breast cancer onset and progression. Understanding the biological functions and underlying molecular mechanisms of dysregulated circRNAs in breast cancer is crucial for elucidating its pathogenesis and identifying potential therapeutic targets. In this study, we investigated the role and molecular mechanism of circGSK3β in breast cancer. We found that circGSK3β is highly expressed in breast cancer cell lines, where it promotes cell proliferation, migration, and invasion, thereby driving breast cancer progression. Furthermore, we observed a close association between circGSK3β expression levels and immune evasion in breast cancer cells. Mechanistically, circGSK3β acts as a competing endogenous RNA (ceRNA) by interacting with miR-338-3p, thereby promoting breast cancer cell proliferation, migration, and invasion. Additionally, circGSK3β positively regulates the expression of the target gene PRMT5 through its interaction with miR-338-3p. This, in turn, enhances H3K4me3 recruitment to the promoter region of PD-L1, resulting in upregulation of PD-L1 expression and consequent immune evasion in breast cancer. In summary, our findings underscore the significance of the circGSK3β-miR-338-3p-PRMT5-H3K4me3 axis in promoting breast cancer progression and immune evasion. CircGSK3β emerges as a critical player in breast cancer pathogenesis, potentially serving as a diagnostic and prognostic marker, and offering novel insights into the role of circRNAs in breast cancer progression.

摘要

环状RNA(circRNA)在乳腺癌的发生和发展中起着关键作用。了解乳腺癌中失调的circRNA的生物学功能和潜在分子机制对于阐明其发病机制和确定潜在治疗靶点至关重要。在本研究中,我们调查了circGSK3β在乳腺癌中的作用和分子机制。我们发现circGSK3β在乳腺癌细胞系中高表达,它促进细胞增殖、迁移和侵袭,从而推动乳腺癌进展。此外,我们观察到circGSK3β表达水平与乳腺癌细胞免疫逃逸之间存在密切关联。机制上,circGSK3β通过与miR-338-3p相互作用作为竞争性内源RNA(ceRNA),从而促进乳腺癌细胞增殖、迁移和侵袭。此外,circGSK3β通过与miR-338-3p相互作用正向调节靶基因PRMT5的表达。这反过来增强了H3K4me3募集到PD-L1启动子区域,导致PD-L1表达上调,进而导致乳腺癌免疫逃逸。总之,我们的研究结果强调了circGSK3β-miR-338-3p-PRMT5-H3K4me3轴在促进乳腺癌进展和免疫逃逸中的重要性。CircGSK3β成为乳腺癌发病机制中的关键因素,可能作为诊断和预后标志物,并为circRNA在乳腺癌进展中的作用提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/898d1258ade6/41420_2024_2197_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/88134a214486/41420_2024_2197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/4af13eb44906/41420_2024_2197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/d4dfb3c5d0f5/41420_2024_2197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/a225eb0d7068/41420_2024_2197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/57b675ff03e7/41420_2024_2197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/5b1c83f80536/41420_2024_2197_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/898d1258ade6/41420_2024_2197_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/88134a214486/41420_2024_2197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/4af13eb44906/41420_2024_2197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/d4dfb3c5d0f5/41420_2024_2197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/a225eb0d7068/41420_2024_2197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/57b675ff03e7/41420_2024_2197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/5b1c83f80536/41420_2024_2197_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdae/11452702/898d1258ade6/41420_2024_2197_Fig7_HTML.jpg

相似文献

1
CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.环状糖原合成酶激酶3β(CircGSK3β)通过微小RNA-338-3p/蛋白精氨酸甲基转移酶5/组蛋白H3赖氨酸4三甲基化(miR-338-3p/PRMT5/H3K4me3)介导程序性死亡受体配体1(PD-L1)转录,以促进乳腺癌细胞的免疫逃逸和肿瘤进展。
Cell Death Discov. 2024 Oct 4;10(1):426. doi: 10.1038/s41420-024-02197-8.
2
circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.环状 GSK3β 通过增强β-catenin 信号促进食管鳞癌细胞转移。
Mol Cancer. 2019 Nov 14;18(1):160. doi: 10.1186/s12943-019-1095-y.
3
Circ_0000052/miR-382-3p axis induces PD-L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma.环状 RNA 0000052/miR-382-3p 轴诱导 PD-L1 表达,并调节头颈部鳞状细胞癌中的细胞增殖和免疫逃逸。
J Cell Mol Med. 2023 Jan;27(1):113-126. doi: 10.1111/jcmm.17643. Epub 2022 Dec 14.
4
Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis.外泌体环状RNA RHOT1通过靶向miR-204-5p/PRMT5轴促进乳腺癌进展。
Cancer Cell Int. 2023 Nov 3;23(1):260. doi: 10.1186/s12935-023-03111-5.
5
The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression.circSPON2/miR-331-3p 轴调控 PRMT5,后者是 CAMK2N1 转录和前列腺癌进展的表观遗传调控因子。
Mol Cancer. 2022 May 27;21(1):119. doi: 10.1186/s12943-022-01598-6.
6
N-methyladenosine-modified circIGF2BP3 inhibits CD8 T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.N6-甲基腺苷修饰的环状 IGF2BP3 通过促进非小细胞肺癌中 PD-L1 的去泛素化来抑制 CD8 T 细胞反应,从而促进肿瘤免疫逃逸。
Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4.
7
Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.Hsa_circ_0046523通过调控胰腺癌中miR-148a-3p/PD-L1轴介导免疫抑制性肿瘤微环境。
Front Oncol. 2022 May 30;12:877376. doi: 10.3389/fonc.2022.877376. eCollection 2022.
8
The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.环状 RNA circDLG1 通过海绵吸附 miR-141-3p 调控 CXCL12 促进胃癌进展和抗 PD-1 耐药。
Mol Cancer. 2021 Dec 15;20(1):166. doi: 10.1186/s12943-021-01475-8.
9
Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion.环状RNA circ_0000284通过miR-377-3p介导的程序性死亡受体配体1(PD-L1)上调在非小细胞肺癌进展中发挥致癌作用。
Cancer Cell Int. 2020 Jun 16;20:247. doi: 10.1186/s12935-020-01310-y. eCollection 2020.
10
Circ-PRMT5 promotes breast cancer by the miR-509-3p/TCF7L2 axis activating the PI3K/AKT pathway.环状 PRMT5 通过 miR-509-3p/TCF7L2 轴激活 PI3K/AKT 通路促进乳腺癌的发生。
J Gene Med. 2021 Feb;23(2):e3300. doi: 10.1002/jgm.3300. Epub 2020 Dec 27.

引用本文的文献

1
The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome.免疫相关预后基因AIM2通过炎性小体促进胰腺癌进展。
Sci Rep. 2025 Aug 13;15(1):29733. doi: 10.1038/s41598-025-12651-x.
2
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance.环状RNA作为乳腺癌诊断、预后、分子分型、转移和耐药性的生物标志物
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251328500. doi: 10.1177/15330338251328500. Epub 2025 Mar 13.

本文引用的文献

1
circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer.环状 RNA LIFR-007 通过促进乳腺癌中 hnRNPA1 的核输出和 YAP 磷酸化减少肝转移。
Cancer Lett. 2024 Jun 28;592:216907. doi: 10.1016/j.canlet.2024.216907. Epub 2024 Apr 27.
2
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.更正:环状RNA circMET通过miR-30-5p/蜗牛/DPP4轴驱动肝细胞癌中的免疫抑制和抗PD1治疗耐药性。
Mol Cancer. 2024 Feb 29;23(1):44. doi: 10.1186/s12943-024-01969-1.
3
The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer.
非编码 RNA 在肺癌中 EGFR 信号通路中的新兴作用。
Pathol Res Pract. 2024 Jan;253:155016. doi: 10.1016/j.prp.2023.155016. Epub 2023 Dec 5.
4
A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.环状KIF4A- miR-637-STAT3的新型轴促进三阴性乳腺癌的脑转移。
Cancer Lett. 2024 Jan 28;581:216508. doi: 10.1016/j.canlet.2023.216508. Epub 2023 Nov 28.
5
Regulation of microRNA by circular RNA.环状RNA对微小RNA的调控
Wiley Interdiscip Rev RNA. 2023 Oct 2:e1820. doi: 10.1002/wrna.1820.
6
Circular RNAs: Emerging roles and new insights in human cancers.环状 RNA:在人类癌症中的新兴作用和新见解。
Biomed Pharmacother. 2023 Sep;165:115217. doi: 10.1016/j.biopha.2023.115217. Epub 2023 Jul 26.
7
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies.靶向精氨酸甲基转移酶 PRMT5 治疗癌症:最新进展和新策略。
J Med Chem. 2023 Jul 13;66(13):8407-8427. doi: 10.1021/acs.jmedchem.3c00250. Epub 2023 Jun 27.
8
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205.Hsa_circ_0060467通过与eIF4A3结合并吸附miR-1205促进乳腺癌肝转移。
Cell Death Discov. 2023 May 9;9(1):153. doi: 10.1038/s41420-023-01448-4.
9
The Role of PRMT5 in Immuno-Oncology.PRMT5 在肿瘤免疫中的作用。
Genes (Basel). 2023 Mar 9;14(3):678. doi: 10.3390/genes14030678.
10
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives.乳腺癌免疫治疗不断演变的治疗格局:当前问题与未来展望。
Ther Adv Med Oncol. 2023 Jan 19;15:17588359221146129. doi: 10.1177/17588359221146129. eCollection 2023.